Showing 26-30 of 30 :
September 19 – Big Data and Cognitive Computing: The Next Generation of RWE for Rheumatology & Related Immunologic Disorders

September 19, 2017 – 10 am ET Join Kathryn Starzyk, Senior Director of Research and Epidemiology, at OM1, as she discusses the evolving role of big data and cognitive computing in generating real-world evidence for rheumatology and related immunologic disorders. This session will explore how advanced technologies and approaches can be applied to support real-world[…]

Big Data: Hoax or Hero in Real-World Evidence for Cardiovascular and Metabolic Diseases?

On this webinar, Dr. Richard Gliklich, CEO of OM1, discussed the evolving role of big data and cognitive computing in generating real-world evidence for cardiovascular and metabolic diseases. This session explored how innovative methodologies and technologies can be applied to support safety, value, and commercial strategies. Topics covered included: New real-world evidence methodologies and approaches[…]

Outcomes as the Key to Value-based Healthcare: Going From Real World Evidence to Outcomes-Based Contracts

Value-based care is gaining momentum and with that so too are outcomes-based contracts and risk sharing agreements. As payment models increasingly link outcomes to payment, there is a greater need for alignment of outcomes among different stakeholders. Join Dr. Richard Gliklich as he discusses the opportunities and challenges with: Defining measurable outcomes Developing and implementing[…]

The Next Generation of Registries and Real-World Evidence

The needs for real-world evidence continue to grow, but so have the tools. This session will explore the changes in technology, data liquidity, healthcare economics and how they are all combining to change the needs for real-world evidence and the best means to collect, analyze and use it. While registries remain an important component of[…]

1 4 5 6